GOLDMAN SACHS GROUP INC - CHINOOK THERAPEUTICS INC ownership

CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 158 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.5%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CHINOOK THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$19,519,742
+141.4%
508,062
+45.4%
0.00%
+100.0%
Q1 2023$8,086,433
+45.5%
349,306
+64.6%
0.00%
+100.0%
Q4 2022$5,559,011
-29.8%
212,176
-47.3%
0.00%
-50.0%
Q3 2022$7,915,000
+93.6%
402,590
+72.2%
0.00%
+100.0%
Q2 2022$4,088,000
+6.4%
233,729
-0.4%
0.00%0.0%
Q1 2022$3,841,000
+7.9%
234,738
+7.6%
0.00%0.0%
Q4 2021$3,560,000
+43.1%
218,226
+11.9%
0.00%0.0%
Q3 2021$2,487,000
+14.7%
194,937
+27.0%
0.00%
Q2 2021$2,168,000
+637.4%
153,530
+712.1%
0.00%
Q1 2021$294,000
-10.9%
18,905
-9.1%
0.00%
Q4 2020$330,00020,7980.00%
Other shareholders
CHINOOK THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Parallel Advisors, LLC 5$00.00%
View complete list of CHINOOK THERAPEUTICS INC shareholders